News | Digital Radiography (DR) | June 22, 2022

SpectralDR is built into the Reveal 35C detector and family of products 

SpectralDR is currently built into the Reveal 35C detector. The new brand is in line with the company’s strategy to expand its presence in the X-ray market.

June 22, 2022 — Canadian manufacturer KA Imaging unveiled a new brand identity for its patented dual-energy technology. SpectralDR is currently built into the Reveal 35C detector. The new brand is in line with the company’s strategy to expand its presence in the X-ray market. 

“The Reveal 35C detector is a breakthrough and the first in an exciting product roadmap,” said Fernanda Fraga, Marketing Manager of KA Imaging. At this time, Reveal 35C detector is available for sale in Canada, the United States, and other countries globally. Earlier this year, the company announced plans to develop an integrated mobile system powered by its SpectralDR technology. 

KA Imaging’s SpectralDR technology enables dual-energy subtraction, providing bone and tissue differentiation with a single standard X-ray exposure. It acquires three images simultaneously (DR, bone and soft tissue dual-energy X-ray images). The technology mimics the workflow, dose and techniques of state-of-the-art mobile DR X-ray detectors. 

“It's a 3-in-1 solution, as in three images with one exposure to radiation and no extra work. Having a DR plus the supplemental spectral bone and tissue images allows for better diagnosis and faster reading,” said Phil Templeton, M.D., radiologist, and Chief Medical Officer of KA Imaging. The spectral images provide enhanced visualization of different conditions like lung nodules, pneumonia, tips of lines and tubes, pneumothorax and retained surgical bodies. 

Adding a name to the patented technology simplifies the message to the industry. “SpectralDR addresses the drawbacks of previous dual-energy subtraction or bone suppression approaches,” said Dr. Karim S. Karim, CTO of KA Imaging. Conventional dual energy is not mobile and uses two exposures, while bone suppression image quality is limited and cannot provide bone images. “SpectralDR really takes general X-ray to the next level because you can get true bone and soft tissue subtracted images every time plus a DR image in one exposure at the lowest dose. If it’s low dose, 3-in-1, and mobile and single exposure, you can bet it is powered by SpectralDR,” said Karim. 

For more information: www.kaimaging.com 


Related Content

News | ASTRO

Sept. 29, 2026 — The American Society for Radiation Oncology (ASTRO) has named Siemens Healthineers the inaugural ...

Time September 29, 2026
arrow
News | Computed Tomography (CT)

Sept. 17, 2026 — Royal Philips and Southwest Mississippi Regional Medical Center (SMRMC), which serves as the hub of ...

Time September 24, 2026
arrow
News | Radiology Education

Sept. 16, 2026 — As urgent care centers and outpatient healthcare facilities expand their use of diagnostic imaging, the ...

Time September 17, 2026
arrow
News | PET Imaging

Sept. 10, 2026 — Siemens Healthineers Molecular Imaging has completed a $43.6 million construction and renovation ...

Time September 14, 2026
arrow
Feature | Artificial Intelligence | Kyle Hardner

A radiologist pulls up a chest CT scan flagged for a pulmonary nodule. One artificial intelligence (AI) tool writes its ...

Time September 09, 2026
arrow
News | Radiology Business

August 18, 2026 – NewVue, a provider of cloud-native software that unifies how radiologists work while improving ...

Time August 25, 2026
arrow
News | Radiology Imaging

Aug. 13, 2026 — Epic's new Care Everywhere Diagnostic Image Exchange allows health systems using Epic to share ...

Time August 21, 2026
arrow
Feature | Artificial Intelligence | Madhu Jahagirdar

Radiologists spend much of their day moving between different systems: One application to review images. Another to ...

Time August 17, 2026
arrow
News | X-Ray

Aug. 10, 2026 — Teledyne Technologies Inc. and Varex Imaging Corp. have jointly announced that they have entered into a ...

Time August 14, 2026
arrow
News | FDA

Aug. 1, 2026 — Candelis recently announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance ...

Time August 13, 2026
arrow
Subscribe Now